OpenURL Connection Search

Select item for more details and to access through your institution.

Noninvasive Monitoring of Mantle Cell Lymphoma by Immunoglobulin Gene Next-Generation Sequencing in a Phase 2 Study of Sequential Chemoradioimmunotherapy Followed by Autologous Stem-Cell Rescue.
Published in:
2021
By:
- Kumar, Anita;
- Bantilan, K.S.;
- Jacob, A.P.;
- Park, A.;
- Schoninger, S.F.;
- Sauter, C.;
- Ulaner, G.A.;
- Casulo, C.;
- Faham, M.;
- Kong, K.A.;
- Grewal, R.K.;
- Gerecitano, J.;
- Hamilton, A.;
- Hamlin, P.;
- Matasar, M.;
- Moskowitz, C.H.;
- Noy, A.;
- Palomba, M.L.;
- Portlock, C.S.;
- Younes, A.
Publication type:
journal article
NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826.
Published in:
Hematological Oncology, 2023, v. 41, p. 33, doi. 10.1002/hon.3163_5
By:
- Herrera, A. F.;
- LeBlanc, M.;
- Castellino, S. M.;
- Li, H.;
- Rutherford, S. C.;
- Evens, A. M.;
- Davison, K.;
- Punnett, A.;
- Hodgson, D.;
- Parsons, S. K.;
- Ahmed, S.;
- Casulo, C.;
- Bartlett, N. L.;
- Tuscano, J. M.;
- Mei, M. G.;
- Hess, B. T.;
- Jacobs, R.;
- Saeed, H.;
- Torka, P.;
- Hu, B.
Publication type:
Article
Duvelisib in patients with relapsed/refractory peripheral T‐cell lymphoma from the phase 2 PRIMO Trial Expansion Phase: outcomes by baseline histology.
Published in:
Hematological Oncology, 2023, v. 41, p. 499, doi. 10.1002/hon.3164_367
By:
- Mehta‐Shah, N.;
- Jacobsen, E. D.;
- Zinzani, P. L.;
- Zain, J.;
- Mead, M.;
- Casulo, C.;
- Gritti, G.;
- Pinter‐Brown, L.;
- Izutsu, K.;
- Waters, S.;
- Brammer, J. E.;
- Pro, B.;
- Horwitz, S. M.
Publication type:
Article
Venetoclax based combination therapy does not overcome poor outcomes in BTKi‐refractory mantle cell lymphoma: phase 2 trial of umbralisib, ublituximab, and venetoclax.
Published in:
Hematological Oncology, 2023, v. 41, p. 484, doi. 10.1002/hon.3164_356
By:
- Wallace, D. S.;
- Rowland, C.;
- Hill, B. T.;
- Baran, A. M.;
- Casulo, C.;
- Reagan, P. M.;
- Winter, A.;
- Karmali, R.;
- Winter, J. N.;
- Gordon, L. I.;
- Bui, A.;
- Sportelli, P.;
- Weiss, M. S.;
- Miskin, H. P.;
- Friedberg, J. W.;
- Ma, S.;
- Barr, P. M.
Publication type:
Article
Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes.
Published in:
Hematological Oncology, 2023, v. 41, p. 430, doi. 10.1002/hon.3164_317
By:
- Bock, A. M.;
- Mwangi, R.;
- Wang, Y.;
- Khurana, A.;
- Maurer, M. J.;
- Ayers, A.;
- Kahl, B.;
- Martin, P.;
- Cohen, J.;
- Casulo, C.;
- Lossos, I.;
- Farooq, U.;
- Ayyappan, S.;
- Reicks, T.;
- Habermann, T. M.;
- Flowers, C. R.;
- Cerhan, J. R.;
- Nastoupil, L. J.;
- Nowakowski, G. S.
Publication type:
Article
ADDITION OF LENALIDOMIDE TO R‐CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG‐ACRIN1412 A RANDOMIZED PHASE 2 US INTERGROUP STUDY OF R2CHOP VS R‐CHOP.
Published in:
Hematological Oncology, 2019, v. 37, p. 37, doi. 10.1002/hon.6_2629
By:
- Nowakowski, G.S.;
- Hong, F.;
- Scott, D.W.;
- Macon, R.;
- King, R.L.;
- Habermann, T.M.;
- Wagner‐Johnston, N.;
- Casulo, C.;
- Wade, J.L.;
- Nagargoje, G.G.;
- Reynolds, C.M.;
- Cohen, J.B.;
- Khan, N.;
- Amengual, J.;
- Richards, K.L.;
- Little, R.F.;
- Leonard, J.P.;
- Friedberg, J.W.;
- Kostakoglu, L.;
- Kahl, B.S.
Publication type:
Article
CLINICAL OUTCOMES OF PATIENTS WITH INTERMEDIATE‐TO‐HIGH‐RISK FOLLICULAR LYMPHOMA (FL) IN THE GALLIUM PHASE III STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 386, doi. 10.1002/hon.56_2631
By:
- Launonen, A.;
- Casulo, C.;
- Pott, C.;
- Rusconi, C.;
- Hernandez, J.;
- Davies, A.J.
Publication type:
Article
STAGE I‐II NODULAR LYMPHOCYTE‐PREDOMINANT HODGKIN LYMPHOMA IN THE MODERN ERA: A MULTI‐INSTITUTIONAL EXPERIENCE OF ADULT PATIENTS BY ILROG.
Published in:
Hematological Oncology, 2019, v. 37, p. 145, doi. 10.1002/hon.103_2629
By:
- Binkley, M.S.;
- Rauf, M.;
- Milgrom, S.A.;
- Pinnix, C.C.;
- Tsang, R.;
- Ng, A.;
- Roberts, K.B.;
- Gao, S.;
- Ricardi, U.;
- Levis, M.;
- Casulo, C.;
- Stolten, M.;
- Kelsey, C.R.;
- Brady, J.L.;
- Mikhaeel, N.;
- Hoppe, B.S.;
- Terezakis, S.A.;
- Kirova, Y.;
- Akhtar, S.;
- Maghfoor, I.
Publication type:
Article
ADDITION OF LENALIDOMIDE TO R‐CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG‐ACRIN1412 A RANDOMIZED PHASE 2 US INTERGROUP STUDY OF R2CHOP VS R‐CHOP.
Published in:
Hematological Oncology, 2019, v. 37, p. 37, doi. 10.1002/hon.6_2629
By:
- Nowakowski, G.S.;
- Hong, F.;
- Scott, D.W.;
- Macon, R.;
- King, R.L.;
- Habermann, T.M.;
- Wagner‐Johnston, N.;
- Casulo, C.;
- Wade, J.L.;
- Nagargoje, G.G.;
- Reynolds, C.M.;
- Cohen, J.B.;
- Khan, N.;
- Amengual, J.;
- Richards, K.L.;
- Little, R.F.;
- Leonard, J.P.;
- Friedberg, J.W.;
- Kostakoglu, L.;
- Kahl, B.S.
Publication type:
Article
CLINICAL OUTCOMES OF PATIENTS WITH INTERMEDIATE‐TO‐HIGH‐RISK FOLLICULAR LYMPHOMA (FL) IN THE GALLIUM PHASE III STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 386, doi. 10.1002/hon.56_2631
By:
- Launonen, A.;
- Casulo, C.;
- Pott, C.;
- Rusconi, C.;
- Hernandez, J.;
- Davies, A.J.
Publication type:
Article
STAGE I‐II NODULAR LYMPHOCYTE‐PREDOMINANT HODGKIN LYMPHOMA IN THE MODERN ERA: A MULTI‐INSTITUTIONAL EXPERIENCE OF ADULT PATIENTS BY ILROG.
Published in:
Hematological Oncology, 2019, v. 37, p. 145, doi. 10.1002/hon.103_2629
By:
- Binkley, M.S.;
- Rauf, M.;
- Milgrom, S.A.;
- Pinnix, C.C.;
- Tsang, R.;
- Ng, A.;
- Roberts, K.B.;
- Gao, S.;
- Ricardi, U.;
- Levis, M.;
- Casulo, C.;
- Stolten, M.;
- Kelsey, C.R.;
- Brady, J.L.;
- Mikhaeel, N.;
- Hoppe, B.S.;
- Terezakis, S.A.;
- Kirova, Y.;
- Akhtar, S.;
- Maghfoor, I.
Publication type:
Article
AUTOLOGOUS TRANSPLANTATION IMPROVES SURVIVAL IN PATIENTS WITH FOLLICULAR LYMPHOMA EXPERIENCING EARLY THERAPY FAILURE AFTER FRONTLINE CHEMOIMMUNOTHERAPY: AN NLCS AND CIBMTR ANALYSIS.
Published in:
Hematological Oncology, 2017, v. 35, p. 222, doi. 10.1002/hon.2438_86
By:
- Casulo, C.;
- Friedberg, J.W.;
- Ahn, K.W.;
- Flowers, C.R.;
- DiGilio, A.
Publication type:
Article
CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR YOUNG PATIENTS WITH FIRST-LINE FOLLICULAR LYMPHOMA: A POOLED ANALYSIS OF 4249 PATIENTS FROM THE FLASH DATABASE.
Published in:
Hematological Oncology, 2017, v. 35, p. 225, doi. 10.1002/hon.2438_89
By:
- Fornecker, L.;
- Ou, F.;
- Dixon, J.G.;
- Casulo, C.;
- Hoster, E.;
- Hiddemann, W.;
- Sebban, C.;
- Morschhauser, F.;
- Marcus, R.;
- Hochster, H.;
- Rummel, M.;
- Hagenbeeck, A.;
- Kimby, E.;
- Herold, M.;
- Peterson, B.A.;
- Gyan, E.;
- Ladetto, M.;
- Zucca, E.;
- Nielsen, T.;
- Foon, K.
Publication type:
Article
A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 GY INVOLVED-SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 171, doi. 10.1002/hon.2438_30
By:
- Kumar, A.;
- Casulo, C.;
- Advani, R.;
- Budde, E.;
- Barr, P.M.;
- Batlevi, C.L.;
- Chen, R.;
- Constine, L.S.;
- Courtien, A.I.;
- Dandapani, S.V.;
- Drullinsky, P.;
- Friedberg, J.W.;
- Hamlin, P.A.;
- Hoppe, R.T.;
- Matasar, M.J.;
- McArthur, G.N.;
- Miller, S.T.;
- Moskowitz, A.J.;
- Noy, A.;
- Schoder, H.
Publication type:
Article
OUTCOMES OF ADULTS, ADOLESCENTS, AND CHILDREN WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA TREATED WITH DOSE-ADJUSTED EPOCH-R THERAPY: a MULTICENTER RETROSPECTIVE ANALYSIS.
Published in:
Hematological Oncology, 2017, v. 35, p. 61, doi. 10.1002/hon.2437_48
By:
- Roth, L.G.;
- O'Donohue, T.;
- Chen, Z.;
- Bartlett, N.;
- Martin ‐ Doyle, W.;
- Barth, M.J.;
- Davies, K.;
- Christian, B.;
- Casulo, C.;
- Godfrey, J.;
- Oberley, M.J.;
- Alexander, S.;
- Weitzman, S.;
- Appel, B.;
- Svoboda, J.;
- Afify, Z.;
- Pauly, M.;
- Dave, H.;
- Gardner, R.;
- Stephens, D.M.
Publication type:
Article
HIGH RATE OF MORBID CENTRAL LINE ASSOCIATED COMPLICATIONS DURING TREATMENT WITH DOSE-ADJUSTED R-EPOCH THERAPY FOR NON-HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 413, doi. 10.1002/hon.2439_193
By:
- Reagan, P.;
- David, R.;
- Baran, A.;
- Kelly, J.;
- Loh, K.;
- Casulo, C.;
- Barr, P.;
- Friedberg, J.
Publication type:
Article
HIGH-RISK PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA ARE NOT ENROLLED ON CLINICAL TRIALS.
Published in:
Hematological Oncology, 2017, v. 35, p. 181, doi. 10.1002/hon.2438_42
By:
- Reagan, P.;
- Loh, K.P.;
- Baran, A.;
- Hu, J.;
- Casulo, C.;
- Barr, P.M.;
- Friedberg, J.W.
Publication type:
Article

Found: 17